LAMIVUDINE Side Effects

7017556-5 | Uveitis
on May 11, 2010 Male patient from SINGAPORE , 60 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with Lamivudine (View Usage). Patient experienced the following unwanted or unexpected effects: uveitis. Lamivudine dosage: . During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

7007121-8 | Disease Recurrence, Immune Reconstitution Syndrome, Placental Disorder, Toxoplasmosis
Patient was taking Lamivudine (View Usage). Patient had the following side effects: disease recurrence, immune reconstitution syndrome, placental disorder, toxoplasmosis on Aug 24, 2010 from FRANCE Additional patient health information: Female patient , 26 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Lamivudine dosage: . During the same period patient was treated with LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ), COTRIM (View Cotrim Review and Cotrim Label ).

7004667-3 | Immune Reconstitution Syndrome, Tuberculosis
Adverse event was reported on Sep 07, 2010 by a Male patient taking Lamivudine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: INDIA , 53 years of age, After Lamivudine was administered, patient had the following side effects: immune reconstitution syndrome, tuberculosis (What is tuberculosis?). During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ATORVASTATIN (20 Mg, Unk) (View Atorvastatin Review and Atorvastatin Label ), COTRIM (View Cotrim Review and Cotrim Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), ONCOVIN (View Oncovin Review and Oncovin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6987233-5 | Immune Reconstitution Syndrome, Tuberculosis
on Sep 02, 2010 Male patient from INDIA , 53 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Lamivudine (View Usage). Patient experienced the following unwanted or unexpected effects: immune reconstitution syndrome, tuberculosis (What is tuberculosis?). Lamivudine dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ).


6973847-5 | Blood Creatinine Increased, Immune Reconstitution Syndrome, Pulmonary Sarcoidosis
on Sep 02, 2010 Male patient from JAPAN , 26 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Lamivudine (View Usage). Patient had the following side effects: blood creatinine increased, immune reconstitution syndrome, pulmonary sarcoidosis. Lamivudine dosage: . During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), LOPINAVIR/RITONAVIR (View Lopinavir/ritonavir Review and Lopinavir/ritonavir Label ), ATAZANAVIR (View Atazanavir Review and Atazanavir Label ). Patient was hospitalized.

6922882-1 | Basedow's Disease, Goitre, Pneumonia
Patient was taking Lamivudine (View Usage). After Lamivudine was administered, patient had the following side effects: basedow's disease, goitre, pneumonia (What is pneumonia?) on Jul 30, 2010 from UNITED STATES Additional patient health information: Male patient , child 11 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Lamivudine dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ).

6878669-1 | Abortion Spontaneous, Placental Infarction, Umbilical Cord Abnormality
Adverse event was reported on Jul 22, 2010 by a Female patient taking Lamivudine (View Usage) (Dosage: 300mg Per Day) was diagnosed with retroviral infection, cytomegalovirus infection (What is cytomegalovirus infection?) and. Location: UNITED KINGDOM , 31 years of age, weighting 133.4 lb, Patient experienced the following unwanted or unexpected effects: abortion spontaneous, placental infarction, umbilical cord abnormality. During the same period patient was treated with VALGANCICLOVIR HCL (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ), DIDANOSINE (250mg Per Day) (View Didanosine Review and Didanosine Label ), REYATAZ (300mg Per Day) (View Reyataz Review and Reyataz Label ), NORVIR (100mg Per Day) (View Norvir Review and Norvir Label ), FUZEON (180mg Per Day) (View Fuzeon Review and Fuzeon Label ), COTRIM (View Cotrim Review and Cotrim Label ).

6874688-X | Ataxia, Cataract, Chorioretinal Scar, Cytomegalovirus Viraemia, Eye Disorder, Eye Inflammation, Fibrosis, Fungal Test Positive, Granuloma
on Jul 13, 2010 Female patient from FINLAND , 35 years of age, was diagnosed with hiv test positive (What is hiv test positive?) and was treated with Lamivudine (View Usage). Patient had the following side effects: ataxia (What is ataxia?), cataract (What is cataract?), chorioretinal scar, cytomegalovirus viraemia, eye disorder, eye inflammation, fibrosis, fungal test positive, granuloma. Lamivudine dosage: . During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ). Patient was hospitalized.

6870166-2 | Progressive Multifocal Leukoencephalopathy, Visual Impairment
on Jul 09, 2010 Male patient from UNITED STATES , 51 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Lamivudine (View Usage). After Lamivudine was administered, patient had the following side effects: progressive multifocal leukoencephalopathy, visual impairment. Lamivudine dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6870165-0 | Central Nervous System Lesion, Jc Virus Test Positive, Progressive Multifocal Leukoencephalopathy, Trigeminal Palsy, Viith Nerve Paralysis, Vith Nerve Paralysis
Patient was taking Lamivudine (View Usage). Patient experienced the following unwanted or unexpected effects: central nervous system lesion, jc virus test positive, progressive multifocal leukoencephalopathy, trigeminal palsy, viith nerve paralysis, vith nerve paralysis on Jul 09, 2010 from UNITED STATES Additional patient health information: Male patient , 35 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Lamivudine dosage: . During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ).

6819047-0 | Immune Reconstitution Syndrome
Adverse event was reported on Jun 23, 2010 by a Male patient taking Lamivudine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: COLOMBIA , 47 years of age, Patient had the following side effects: immune reconstitution syndrome. During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ). Patient was hospitalized.

6766052-9 | Asphyxia, Premature Labour, Respiratory Distress, Stillbirth
on Jun 30, 2008 Female patient from SOUTH AFRICA , 40 years of age, was diagnosed with tuberculosis (What is tuberculosis?) and was treated with Lamivudine (View Usage). After Lamivudine was administered, patient had the following side effects: asphyxia, premature labour, respiratory distress, stillbirth. Lamivudine dosage: 300mg Per Day. During the same period patient was treated with STAVUDINE (60mg Per Day) (View Stavudine Review and Stavudine Label ), EFAVIRENZ (600mg Per Day) (View Efavirenz Review and Efavirenz Label ), RIFAFOUR (View Rifafour Review and Rifafour Label ).

6754817-9 | Cytomegalovirus Chorioretinitis, Uveitis
on May 11, 2010 Male patient from SINGAPORE , 60 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with Lamivudine (View Usage). Patient experienced the following unwanted or unexpected effects: cytomegalovirus chorioretinitis, uveitis. Lamivudine dosage: . During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6750575-2 | Progressive Multifocal Leukoencephalopathy
Patient was taking Lamivudine (View Usage). Patient had the following side effects: progressive multifocal leukoencephalopathy on May 18, 2010 from UNITED STATES Additional patient health information: Male patient , 51 years of age, . Lamivudine dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ).

6750574-0 | Progressive Multifocal Leukoencephalopathy
Adverse event was reported on May 18, 2010 by a Male patient taking Lamivudine (View Usage) (Dosage: ) . Location: UNITED STATES , 35 years of age, After Lamivudine was administered, patient had the following side effects: progressive multifocal leukoencephalopathy. During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), CIDOFOVIR (View Cidofovir Review and Cidofovir Label ).

6750568-5 | Progressive Multifocal Leukoencephalopathy
on May 18, 2010 Female patient from UNITED STATES , 52 years of age, was treated with Lamivudine (View Usage). Patient experienced the following unwanted or unexpected effects: progressive multifocal leukoencephalopathy. Lamivudine dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), INDINAVIR (View Indinavir Review and Indinavir Label ), CIDOFOVIR (View Cidofovir Review and Cidofovir Label ).

6750566-1 | Progressive Multifocal Leukoencephalopathy
on May 18, 2010 Female patient from UNITED STATES , 52 years of age, was treated with Lamivudine (View Usage). Patient had the following side effects: progressive multifocal leukoencephalopathy. Lamivudine dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), INDINAVIR (View Indinavir Review and Indinavir Label ), CIDOFOVIR (View Cidofovir Review and Cidofovir Label ).

6750560-0 | Progressive Multifocal Leukoencephalopathy
Patient was taking Lamivudine (View Usage). After Lamivudine was administered, patient had the following side effects: progressive multifocal leukoencephalopathy on May 18, 2010 from UNITED STATES Additional patient health information: Male patient , 36 years of age, . Lamivudine dosage: . During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), NELFINAVIR (View Nelfinavir Review and Nelfinavir Label ), CIDOFOVIR (View Cidofovir Review and Cidofovir Label ).

6732905-0 | Abasia, Aphasia, Body Dysmorphic Disorder, Cataract, Congenital Anomaly, Developmental Delay, Hypotonia, Lactic Acidosis
Adverse event was reported on May 07, 2010 by a Female patient taking Lamivudine (View Usage) (Dosage: Transplacentary) was diagnosed with antiviral prophylaxis and. Location: UNITED STATES , child 4 years of age, Patient experienced the following unwanted or unexpected effects: abasia, aphasia (What is aphasia?), body dysmorphic disorder, cataract (What is cataract?), congenital anomaly, developmental delay, hypotonia, lactic acidosis. During the same period patient was treated with NELFINAVIR MESYLATE (Transplacentary) (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), RETROVIR (Transplacentary) (View Retrovir Review and Retrovir Label ).

6698980-7 | Cytomegalovirus Chorioretinitis, Eye Pain, Ocular Hyperaemia, Uveitis, Vision Blurred, Vitreous Floaters
on Apr 16, 2010 Male patient from SINGAPORE , 60 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with Lamivudine (View Usage). Patient had the following side effects: cytomegalovirus chorioretinitis, eye pain, ocular hyperaemia, uveitis, vision blurred, vitreous floaters. Lamivudine dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ).

6685085-4 | Hyperglycaemia, Hyperlipidaemia, Proteinuria, Type 2 Diabetes Mellitus
on Apr 12, 2010 Female patient from UNITED KINGDOM , 49 years of age, weighting 132.3 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Lamivudine (View Usage). After Lamivudine was administered, patient had the following side effects: hyperglycaemia, hyperlipidaemia, proteinuria, type 2 diabetes mellitus. Lamivudine dosage: . During the same period patient was treated with DARUNAVIR (1200mg Per Day) (View Darunavir Review and Darunavir Label ), ETRAVIRINE (400mg Per Day) (View Etravirine Review and Etravirine Label ), TRUVADA (View Truvada Review and Truvada Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), MARAVIROC (View Maraviroc Review and Maraviroc Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6679669-7 | Hyperlipidaemia, Proteinuria, Type 2 Diabetes Mellitus
Patient was taking Lamivudine (View Usage). Patient experienced the following unwanted or unexpected effects: hyperlipidaemia, proteinuria, type 2 diabetes mellitus on Apr 07, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 44 years of age, weighting 132.3 lb, was diagnosed with hiv infection (What is hiv infection?) and. Lamivudine dosage: . During the same period patient was treated with DARUNAVIR (1200mg Per Day) (View Darunavir Review and Darunavir Label ), ETRAVIRINE (400mg Per Day) (View Etravirine Review and Etravirine Label ), TENOFOVIR (View Tenofovir Review and Tenofovir Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), MARAVIROC (View Maraviroc Review and Maraviroc Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

6675485-0 | Cough, Nasopharyngitis, Pyrexia
Adverse event was reported on Mar 31, 2010 by a Female patient taking Lamivudine (View Usage) (Dosage: 30mg Twice Per Day) was diagnosed with hiv infection (What is hiv infection?), prophylaxis, ill-defined disorder and. Location: INDIA , weighting 20.06 lb, Patient had the following side effects: cough, nasopharyngitis, pyrexia. During the same period patient was treated with ZIDOVUDINE (80mg Twice Per Day) (View Zidovudine Review and Zidovudine Label ), NEVIRAPINE (90mg Twice Per Day) (View Nevirapine Review and Nevirapine Label ), COTRIM (View Cotrim Review and Cotrim Label ), TONOFERON (View Tonoferon Review and Tonoferon Label ).

6666056-0 | Cough, Nasopharyngitis, Pyrexia
on Mar 29, 2010 Female patient from INDIA , weighting 20.06 lb, was diagnosed with hiv infection (What is hiv infection?), prophylaxis, ill-defined disorder and was treated with Lamivudine (View Usage). After Lamivudine was administered, patient had the following side effects: cough, nasopharyngitis, pyrexia. Lamivudine dosage: 30mg Twice Per Day. During the same period patient was treated with ZIDOVUDINE (80mg Twice Per Day) (View Zidovudine Review and Zidovudine Label ), NEVIRAPINE (90mg Twice Per Day) (View Nevirapine Review and Nevirapine Label ), COTRIM (View Cotrim Review and Cotrim Label ), TONOFERON (View Tonoferon Review and Tonoferon Label ).

6656120-4 | Arthritis, Cd4 Lymphocytes, Condition Aggravated, Immune Reconstitution Syndrome, Infection, Lymphadenopathy, Penicilliosis, Pyrexia, Skin Lesion
on Mar 19, 2010 Male patient from INDIA , child 12 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Lamivudine (View Usage). Patient experienced the following unwanted or unexpected effects: arthritis (What is arthritis?), cd4 lymphocytes, condition aggravated, immune reconstitution syndrome, infection (What is infection?), lymphadenopathy, penicilliosis, pyrexia, skin lesion. Lamivudine dosage: . During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), ITRACONAZOLE (200mg Per Day) (View Itraconazole Review and Itraconazole Label ).

6656102-2 | Abdominal Distension, Nausea, Stevens-johnson Syndrome, Viral Load Increased, Weight Decreased
Patient was taking Lamivudine (View Usage). Patient had the following side effects: abdominal distension, nausea (What is nausea?), stevens-johnson syndrome, viral load increased, weight decreased on Mar 16, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 41 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Lamivudine dosage: . During the same period patient was treated with RITONAVIR (View Ritonavir Review and Ritonavir Label ), RALTEGRAVIR POTASSIUM (View Raltegravir Potassium Review and Raltegravir Potassium Label ), DARUNAVIR (1200mg Per Day) (View Darunavir Review and Darunavir Label ), MARAVIROC (300mg Per Day) (View Maraviroc Review and Maraviroc Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

6653857-8 |
Adverse event was reported on Mar 24, 2010 by a Female patient taking Lamivudine (View Usage) (Dosage: 30mg Twice Per Day) was diagnosed with hiv infection (What is hiv infection?), prophylaxis, ill-defined disorder and. Location: INDIA , weighting 20.06 lb, . During the same period patient was treated with ZIDOVUDINE (80mg Twice Per Day) (View Zidovudine Review and Zidovudine Label ), NEVIRAPINE (90mg Twice Per Day) (View Nevirapine Review and Nevirapine Label ), COTRIM (View Cotrim Review and Cotrim Label ), TONOFERON (View Tonoferon Review and Tonoferon Label ).

6622016-7 | Economic Problem, Mobility Decreased, Osteonecrosis
on Feb 22, 2010 Male patient from COTE D'IVOIRE , 44 years of age, weighting 149.6 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Lamivudine (View Usage). Patient experienced the following unwanted or unexpected effects: economic problem, mobility decreased, osteonecrosis (What is osteonecrosis?). Lamivudine dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), ABACAVIR SULFATE (View Abacavir Sulfate Review and Abacavir Sulfate Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), DIDANOSINE (View Didanosine Review and Didanosine Label ), LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ). Patient was hospitalized.

6621934-3 | Blood Hiv Rna Increased, Disease Recurrence, Hepatitis B
on Feb 20, 2010 Male patient from UNITED STATES , 46 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Lamivudine (View Usage). Patient had the following side effects: blood hiv rna increased (What is blood hiv rna increased?), disease recurrence, hepatitis b (What is hepatitis b?). Lamivudine dosage: . During the same period patient was treated with ABACAVIR SULFATE (View Abacavir Sulfate Review and Abacavir Sulfate Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ).

6612076-1 | Lactic Acidosis, Liver Injury
Patient was taking Lamivudine (View Usage). After Lamivudine was administered, patient had the following side effects: lactic acidosis, liver injury on Feb 24, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 39 years of age, was diagnosed with immunosuppression and. Lamivudine dosage: . During the same period patient was treated with ABACAVIR (View Abacavir Review and Abacavir Label ), PROGRAF (16mg Per Day) (View Prograf Review and Prograf Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), TERBINAFINE HCL (View Terbinafine Hcl Review and Terbinafine Hcl Label ), NEORAL (View Neoral Review and Neoral Label ).

6612068-2 | Muscular Weakness, Paralysis, Progressive Multifocal Leukoencephalopathy
Adverse event was reported on Feb 21, 2010 by a Male patient taking Lamivudine (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: CHINA , 37 years of age, Patient experienced the following unwanted or unexpected effects: muscular weakness, paralysis (What is paralysis?), progressive multifocal leukoencephalopathy. During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ). Patient was hospitalized.

6612067-0 | Asthenia, Movement Disorder, Mutism, Nervous System Disorder, Progressive Multifocal Leukoencephalopathy
on Feb 21, 2010 Male patient from CHINA , 40 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Lamivudine (View Usage). Patient had the following side effects: asthenia, movement disorder (What is movement disorder?), mutism, nervous system disorder, progressive multifocal leukoencephalopathy. Lamivudine dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), INDINAVIR (View Indinavir Review and Indinavir Label ).

6612066-9 | Progressive Multifocal Leukoencephalopathy, Visual Field Defect
on Feb 21, 2010 Male patient from CHINA , 36 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Lamivudine (View Usage). After Lamivudine was administered, patient had the following side effects: progressive multifocal leukoencephalopathy, visual field defect. Lamivudine dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), INDINAVIR (View Indinavir Review and Indinavir Label ).

6612065-7 | Abdominal Pain, Nephrolithiasis, Red Blood Cells Urine
Patient was taking Lamivudine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), nephrolithiasis, red blood cells urine on Feb 21, 2010 from CHINA Additional patient health information: Female patient , 42 years of age, . Lamivudine dosage: .

6612064-5 | Abdominal Pain, Calculus Ureteric, Red Blood Cells Urine Positive
Adverse event was reported on Feb 21, 2010 by a Female patient taking Lamivudine (View Usage) (Dosage: ) . Location: CHINA , 36 years of age, Patient had the following side effects: abdominal pain (What is abdominal pain?), calculus ureteric, red blood cells urine positive.

6612063-3 | Leukopenia, Neutropenia, Platelet Count Decreased, Red Blood Cell Count Decreased
on Feb 21, 2010 Male patient from CHINA , 29 years of age, was treated with Lamivudine (View Usage). After Lamivudine was administered, patient had the following side effects: leukopenia, neutropenia, platelet count decreased, red blood cell count decreased. Lamivudine dosage: .

6612062-1 | Leukopenia, Neutropenia, Platelet Count Decreased, Red Blood Cell Count Decreased
on Feb 21, 2010 Female patient from CHINA , 36 years of age, was treated with Lamivudine (View Usage). Patient experienced the following unwanted or unexpected effects: leukopenia, neutropenia, platelet count decreased, red blood cell count decreased. Lamivudine dosage: 100mg Per Day.

6612060-8 | Angioedema, Asthma, Cyanosis, Hypersensitivity, Hypotension, Oropharyngeal Swelling, Swollen Tongue, Urticaria
Patient was taking Lamivudine (View Usage). Patient had the following side effects: angioedema, asthma (What is asthma?), cyanosis, hypersensitivity, hypotension, oropharyngeal swelling, swollen tongue, urticaria on Feb 21, 2010 from CHINA Additional patient health information: Male patient , 49 years of age, was diagnosed with hepatitis b (What is hepatitis b?) and. Lamivudine dosage: . Patient was hospitalized.

6609413-0 | Viraemia, Virologic Failure
Adverse event was reported on Feb 09, 2010 by a Male patient taking Lamivudine (View Usage) (Dosage: ) was diagnosed with hepatitis b (What is hepatitis b?) and. Location: GERMANY , 21 years of age, After Lamivudine was administered, patient had the following side effects: viraemia, virologic failure. During the same period patient was treated with ADEFOVIR DIPIVOXIL KIT (View Adefovir Dipivoxil Kit Review and Adefovir Dipivoxil Kit Label ).

6601252-X | Aphasia, Cognitive Disorder, Dysphagia, Facial Palsy, Hemiplegia, Immune Reconstitution Syndrome, No Therapeutic Response, Nuclear Magnetic Resonance Imaging Brain Abnormal, Progressive Multifocal Leukoencephalopathy
on Feb 02, 2010 Male patient from FRANCE , 38 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Lamivudine (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), cognitive disorder, dysphagia, facial palsy, hemiplegia, immune reconstitution syndrome, no therapeutic response, nuclear magnetic resonance imaging brain abnormal, progressive multifocal leukoencephalopathy. Lamivudine dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6597072-5 | Alanine Aminotransferase Abnormal, Hepatitis B, Pathogen Resistance, Viral Infection
on Feb 23, 2010 Male patient from JAPAN , 52 years of age, was treated with Lamivudine (View Usage). Patient had the following side effects: alanine aminotransferase abnormal, hepatitis b (What is hepatitis b?), pathogen resistance, viral infection (What is viral infection?). Lamivudine dosage: 100mg Per Day. During the same period patient was treated with ADEFOVIR DIPIVOXIL KIT (View Adefovir Dipivoxil Kit Review and Adefovir Dipivoxil Kit Label ), ENTECAVIR (.5mg Per Day) (View Entecavir Review and Entecavir Label ), INSULIN (View Insulin Review and Insulin Label ).

6594423-2 | Alanine Aminotransferase Abnormal, Hepatitis B, Pathogen Resistance, Viral Infection
Patient was taking Lamivudine (View Usage). After Lamivudine was administered, patient had the following side effects: alanine aminotransferase abnormal, hepatitis b (What is hepatitis b?), pathogen resistance, viral infection (What is viral infection?) on Feb 15, 2010 from JAPAN Additional patient health information: Male patient , 52 years of age, . Lamivudine dosage: 100mg Per Day. During the same period patient was treated with ADEFOVIR DIPIVOXIL KIT (View Adefovir Dipivoxil Kit Review and Adefovir Dipivoxil Kit Label ), ENTECAVIR (.5mg Per Day) (View Entecavir Review and Entecavir Label ), INSULIN (View Insulin Review and Insulin Label ).

6594423-2 | Alanine Aminotransferase Abnormal, Hepatitis B, Pathogen Resistance, Viral Infection
Adverse event was reported on Feb 15, 2010 by a Male patient taking Lamivudine (View Usage) (Dosage: 100mg Per Day) . Location: JAPAN , 52 years of age, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase abnormal, hepatitis b (What is hepatitis b?), pathogen resistance, viral infection (What is viral infection?). During the same period patient was treated with ADEFOVIR DIPIVOXIL KIT (View Adefovir Dipivoxil Kit Review and Adefovir Dipivoxil Kit Label ), ENTECAVIR (.5mg Per Day) (View Entecavir Review and Entecavir Label ), INSULIN (View Insulin Review and Insulin Label ).

6594409-8 | Anaemia, Hepatic Enzyme Increased, Hepatomegaly, Hyperthermia, Immune Reconstitution Syndrome, Lymph Node Tuberculosis, Lymphadenopathy, Productive Cough
on Feb 10, 2010 Female patient from GABON , 38 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Lamivudine (View Usage). Patient had the following side effects: anaemia, hepatic enzyme increased, hepatomegaly, hyperthermia, immune reconstitution syndrome, lymph node tuberculosis, lymphadenopathy, productive cough. Lamivudine dosage: 300mg Per Day. During the same period patient was treated with STAVUDINE (60mg Per Day) (View Stavudine Review and Stavudine Label ), EFAVIRENZ (600mg Per Day) (View Efavirenz Review and Efavirenz Label ). Patient was hospitalized.

6594409-8 | Anaemia, Hepatic Enzyme Increased, Hepatomegaly, Hyperthermia, Immune Reconstitution Syndrome, Lymph Node Tuberculosis, Lymphadenopathy, Productive Cough
on Feb 10, 2010 Female patient from GABON , 38 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Lamivudine (View Usage). After Lamivudine was administered, patient had the following side effects: anaemia, hepatic enzyme increased, hepatomegaly, hyperthermia, immune reconstitution syndrome, lymph node tuberculosis, lymphadenopathy, productive cough. Lamivudine dosage: 300mg Per Day. During the same period patient was treated with STAVUDINE (60mg Per Day) (View Stavudine Review and Stavudine Label ), EFAVIRENZ (600mg Per Day) (View Efavirenz Review and Efavirenz Label ). Patient was hospitalized.

6583298-3 | Progressive Multifocal Leukoencephalopathy
Patient was taking Lamivudine (View Usage). Patient experienced the following unwanted or unexpected effects: progressive multifocal leukoencephalopathy on Feb 08, 2010 from CHINA Additional patient health information: Male patient , 37 years of age, . Lamivudine dosage: .

6583297-1 | Progressive Multifocal Leukoencephalopathy
Adverse event was reported on Feb 08, 2010 by a Male patient taking Lamivudine (View Usage) (Dosage: ) . Location: CHINA , 40 years of age, Patient had the following side effects: progressive multifocal leukoencephalopathy.

6583296-X | Progressive Multifocal Leukoencephalopathy
on Feb 08, 2010 Male patient from CHINA , 36 years of age, was treated with Lamivudine (View Usage). After Lamivudine was administered, patient had the following side effects: progressive multifocal leukoencephalopathy. Lamivudine dosage: .

6583295-8 | Nephrolithiasis
on Feb 08, 2010 Female patient from CHINA , 42 years of age, was treated with Lamivudine (View Usage). Patient experienced the following unwanted or unexpected effects: nephrolithiasis. Lamivudine dosage: .

6583294-6 | Calculus Ureteric
Patient was taking Lamivudine (View Usage). Patient had the following side effects: calculus ureteric on Feb 08, 2010 from CHINA Additional patient health information: Female patient , 36 years of age, . Lamivudine dosage: .